Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 35.37
Day High 36.15
Open:35.78
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Data Points to Cannabis Emergence as a Viable Part of Cancer Treatment
PR Newswire - Fri Jul 19, 8:00AM CDT
PR Newswire - CMTX
Fri Jul 19, 8:00AM CDT
The burden of symptoms associated with medical conditions has ravaged millions of people around the globe. Every day, people suffering from medical conditions are distraught by the harsh effects of the symptoms derived from their ailments. For instance, patients receiving cancer therapy can face a plethora of side effects such as nausea and severe pain. Generally, patients may take other medicines in order to subdue these side effects, and in particular, cancer patients suffering from chronic pain may be prescribed opioids from their physician. The major downside of these treatments is that opioids have life-threatening consequences. Overall, cancer patients suffer from side effects associated with cancer therapies as well as the treatments used to control their side effects. As a result, more medical institutions are beginning to recommend cannabis as an alternative to treat the adverse associated with cancer. The American Cancer Society has cited studies that determined that marijuana can be helpful in treating the side effects of cancer chemotherapy. A few studies have even uncovered that inhaled (smoked or vaporized) marijuana can help with the treatment of neuropathic pain. And more recently, scientists have also reported that THC and other cannabinoids such as CBD can slow the growth of and possibly eliminate cancer cells, ultimately reducing the spread of certain forms of cancer. Other studies have suggested that cannabinoids can be safe for humans in treating cancer, which has led to the wide spread of medical cannabis around the world. As more global government agencies collect positive data from clinical trials, more countries will move towards legalizing medical cannabis because of its valuable therapeutic effects. And as a result, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%, according to data compiled by Grand View Research. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), HEXO Corp. (NYSE: HEXO) (TSX: HEXO).
With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp
PR Newswire - Tue Jul 16, 7:30AM CDT
PR Newswire - CMTX
Tue Jul 16, 7:30AM CDT
As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state's thriving industry.
Toxic, Low-Quality CBD Products Putting Consumers at Risk
PR Newswire - Thu Jul 11, 7:55AM CDT
PR Newswire - CMTX
Thu Jul 11, 7:55AM CDT
When the United Kingdom's National Health Service (NHS) made cannabidiols (CBD) legal for medical use in November 2018, the health and wellness applications put in place for the benefit of British consumers seemed nearly boundless. With the rapid growth of the CBD product market, it's becoming more and more important that consumers avoid poor quality products from unregulated, and often unreputable, sources. This means that trusted industry producers such as StillCanna (CSE:STIL) (OTCPK:SCNNF), OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI), Canopy Growth Corp (TSX: WEED) (NYSE: CGC), Aleafia Health (TSX:ALEF) (OTCQX:ALEAF), and The Green Organic Dutchman Holdings (TSX:TGOD) (OTCQX:TGODF) are set to be forerunners in the market.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 33.38 +6.32% increase
on 07/15/19
Period Open:42.77
Price movement based on the high, low and last over the given period.
43.94 -19.23% decrease
on 06/20/19
-7.28 (-17.02%) decrease
since 06/19/19
3-Month 33.38 +6.32% increase
on 07/15/19
Period Open:44.56
Price movement based on the high, low and last over the given period.
52.74 -32.71% decrease
on 04/30/19
-9.07 (-20.35%) decrease
since 04/18/19
52-Week 24.21 +46.59% increase
on 07/20/18
Period Open:25.42
Price movement based on the high, low and last over the given period.
59.25 -40.10% decrease
on 10/16/18
+10.07 (+39.61%) increase
since 07/19/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).